DK521285D0 - Nona- og deka-peptid analoge af lhrh anvendelighed som lhrh-antagonister - Google Patents

Nona- og deka-peptid analoge af lhrh anvendelighed som lhrh-antagonister

Info

Publication number
DK521285D0
DK521285D0 DK521285A DK521285A DK521285D0 DK 521285 D0 DK521285 D0 DK 521285D0 DK 521285 A DK521285 A DK 521285A DK 521285 A DK521285 A DK 521285A DK 521285 D0 DK521285 D0 DK 521285D0
Authority
DK
Denmark
Prior art keywords
lhrh
peptid
nona
deca
analogue
Prior art date
Application number
DK521285A
Other languages
English (en)
Other versions
DK521285A (da
Inventor
John Joseph Nestor
Brian Henry Vickery
Original Assignee
Syntex Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Syntex Inc filed Critical Syntex Inc
Publication of DK521285D0 publication Critical patent/DK521285D0/da
Publication of DK521285A publication Critical patent/DK521285A/da

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K7/00Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/04Linear peptides containing only normal peptide links
    • C07K7/23Luteinising hormone-releasing hormone [LHRH]; Related peptides
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00Drugs for disorders of the urinary system
    • A61P13/02Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00Drugs for genital or sexual disorders; Contraceptives
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10STECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S930/00Peptide or protein sequence
    • Y10S930/01Peptide or protein sequence
    • Y10S930/13Luteinizing hormone-releasing hormone; related peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Public Health (AREA)
  • Engineering & Computer Science (AREA)
  • Endocrinology (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Urology & Nephrology (AREA)
  • Reproductive Health (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Measurement And Recording Of Electrical Phenomena And Electrical Characteristics Of The Living Body (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Semiconductor Memories (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
DK521285A 1984-11-13 1985-11-12 Nona- og deka-peptid analoge af lhrh anvendelighed som lhrh-antagonister DK521285A (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US06/671,153 US4690916A (en) 1984-11-13 1984-11-13 Nona and decapeptide analogs of LHRH useful as LHRH antagonists

Publications (2)

Publication Number Publication Date
DK521285D0 true DK521285D0 (da) 1985-11-12
DK521285A DK521285A (da) 1986-05-14

Family

ID=24693330

Family Applications (1)

Application Number Title Priority Date Filing Date
DK521285A DK521285A (da) 1984-11-13 1985-11-12 Nona- og deka-peptid analoge af lhrh anvendelighed som lhrh-antagonister

Country Status (11)

Country Link
US (1) US4690916A (da)
EP (1) EP0182262B1 (da)
JP (1) JP2542362B2 (da)
AT (1) ATE84797T1 (da)
AU (1) AU594652B2 (da)
CA (1) CA1303627C (da)
DE (1) DE3587016T2 (da)
DK (1) DK521285A (da)
IE (1) IE59709B1 (da)
NZ (1) NZ214154A (da)
ZA (1) ZA858675B (da)

Families Citing this family (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0268066A3 (en) * 1986-10-17 1990-07-11 Syntex (U.S.A.) Inc. Fertility control and uterine therapy in dogs with luteinizing hormone releasing hormone antagonists
US4801577A (en) * 1987-02-05 1989-01-31 Syntex (U.S.A.) Inc. Nonapeptide and decapeptide analogs of LHRH useful as LHRH antagonists
US5688519A (en) * 1987-04-06 1997-11-18 Leonard; Robert J. Flash-flow fused medicinal implants
US4800191A (en) * 1987-07-17 1989-01-24 Schally Andrew Victor LHRH antagonists
NZ226557A (en) * 1987-10-15 1990-07-26 Syntex Inc Pharmaceutical compositions for the intranasal administration of a biologically active polypeptide in powder form and process for their preparation
US5140009A (en) * 1988-02-10 1992-08-18 Tap Pharmaceuticals, Inc. Octapeptide LHRH antagonists
US5110904A (en) * 1989-08-07 1992-05-05 Abbott Laboratories Lhrh analogs
WO1990010437A1 (en) * 1989-03-09 1990-09-20 Endocon, Inc. Partially fused peptide pellet
US5068221A (en) * 1989-05-09 1991-11-26 Mathias John R Treatment of motility disorders with a gnrh analog
US5108760A (en) * 1989-07-21 1992-04-28 Terumo Corporation Enhances lak cell activation by treatment of human peripheral blood mononuclear cells with amino acid amides
US5064939A (en) * 1990-02-06 1991-11-12 The Salk Institute For Biological Studies Cyclic gnrh antagonists
US5783562A (en) * 1990-11-10 1998-07-21 Asta Medica Aktiengesellschaft Luteinizing hormone releasing hormone analogs
US5434136A (en) * 1990-12-14 1995-07-18 Mathias; John R. Treatment of motility disorders with a GNRH analog
TW333456B (en) * 1992-12-07 1998-06-11 Takeda Pharm Ind Co Ltd A pharmaceutical composition of sustained-release preparation the invention relates to a pharmaceutical composition of sustained-release preparation which comprises a physiologically active peptide.
UA61046C2 (en) * 1992-12-07 2003-11-17 Takeda Chemical Industries Ltd Sustained-release preparation and method for its manufacture
US5413990A (en) * 1993-08-06 1995-05-09 Tap Pharmaceuticals Inc. N-terminus modified analogs of LHRH
US5502035A (en) * 1993-08-06 1996-03-26 Tap Holdings Inc. N-terminus modified analogs of LHRH
JP3662926B2 (ja) * 1993-08-06 2005-06-22 タツプ・ホールデイングス・インコーポレイテツド Lhrhのn末端改変類似体
US5730990A (en) * 1994-06-24 1998-03-24 Enzon, Inc. Non-antigenic amine derived polymers and polymer conjugates
US5843901A (en) * 1995-06-07 1998-12-01 Advanced Research & Technology Institute LHRH antagonist peptides
US6407205B1 (en) * 1997-06-04 2002-06-18 Board Of Supervisors Of Louisiana State University And Agricultural And Mechanical College FSH-releasing peptides
CN102464702B (zh) * 2010-12-23 2014-02-19 上海丽珠制药有限公司 制备醋酸亮丙瑞林的方法、产品及用途
WO2019040109A1 (en) 2017-08-21 2019-02-28 Celgene Corporation PROCESSES FOR THE PREPARATION OF (S) -TERT-BUTYL 4,5-DIAMINO-5-OXOPENTANOATE

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2465486A1 (fr) * 1979-09-21 1981-03-27 Roussel Uclaf Nouvelle application utilisant la lh-rh ou des agonistes
DE3163800D1 (en) * 1980-02-12 1984-07-05 Takeda Chemical Industries Ltd Method for protecting guanidino group and restoring the same
US4581169A (en) * 1982-12-21 1986-04-08 Syntex (U.S.A.) Inc. Nona-peptide and deca-peptide analogs of LHRH, useful as LHRH antagonists
FI832053L (fi) * 1982-06-10 1983-12-11 Syntex Inc Nonapeptid- och dekapeptidanaloger av lhrh anvaendbara som lhrh-antagonister samt deras framstaellningsfoerfarande
US4481190A (en) * 1982-12-21 1984-11-06 Syntex (U.S.A.) Inc. Nonapeptide and decapeptide analogs of LHRH useful as LHRH antagonists
IL70888A0 (en) * 1983-03-10 1984-05-31 Salk Inst For Biological Studi Gn rh antagonist peptides and pharmaceutical compositions containing them
DE3467173D1 (en) * 1983-08-16 1987-12-10 Akzo Nv Lh- rh antagonists
US4530920A (en) * 1983-11-07 1985-07-23 Syntex (U.S.A.) Inc. Nonapeptide and decapeptide analogs of LHRH, useful as LHRH agonist

Also Published As

Publication number Publication date
ATE84797T1 (de) 1993-02-15
US4690916A (en) 1987-09-01
EP0182262A2 (en) 1986-05-28
DK521285A (da) 1986-05-14
NZ214154A (en) 1990-07-26
AU594652B2 (en) 1990-03-15
EP0182262B1 (en) 1993-01-20
DE3587016D1 (de) 1993-03-04
AU4982085A (en) 1986-05-22
EP0182262A3 (en) 1988-10-26
IE59709B1 (en) 1994-03-23
ZA858675B (en) 1987-06-24
JP2542362B2 (ja) 1996-10-09
CA1303627C (en) 1992-06-16
IE852815L (en) 1986-05-13
DE3587016T2 (de) 1993-06-03
JPS61122297A (ja) 1986-06-10

Similar Documents

Publication Publication Date Title
DK521285D0 (da) Nona- og deka-peptid analoge af lhrh anvendelighed som lhrh-antagonister
NZ212502A (en) Benzodiazepine analogues and pharmaceutical compositions
AU7941887A (en) Nonapeptide and decapeptide analogs of LHRH useful as LHRH antagonists
ATE46174T1 (de) Octapeptid-vasopressin-antagoniste.
MY122262A (en) Lh-rh peptide analogues their uses and pharmaceutical compositions containing them
DE3853384D1 (de) Peptid.
EE9800173A (et) Gonadotropiini riliisinghormooni antagonistid
ES2044870T3 (es) Un procedimiento para la preparacion de nuevos agentes antihipertensivos.
GR1001129B (el) Ανταγωνιστες ccκ αναλογου αμινοξεος.
DK407985D0 (da) Gnrh antagonister vi
DK0859785T3 (da) Cycliske peptidanaloge af somatostatin
DE69230224D1 (de) Potenzierung von nmda-antagonisten
MX9307610A (es) Decapeptido modificado en la posicion 6 y composicion farmaceutica que locontiene.
UA41300C2 (uk) Аналоги гормонів-антагоністів lhrh і спосіб їх отримання
ZA867423B (en) Peptide antagonists of neurokinin b
ES2164096T3 (es) Antagonistas de lhrh que comprenden restos de aminoacilo modificados en posicion 5 y 6.
GR3021660T3 (en) Anticoagulant peptides
BR9611760A (pt) Novos antagonistas lh-rh com efeito aperfeiçoado
TW336938B (en) Calcium channel blocking polypeptides from filistata hibernalis
ES2061908T3 (es) Antagonistas competitivos de gonadoliberina.
ZA834240B (en) Nonapeptide and decapeptide analogs of lhrh useful as lhrh antagonists
DE3461643D1 (de) Metorphamide - a novel morphine-like peptide
IE862569L (en) Decapeptide antagonists of neurokinin b
GR1001368B (el) Φαρμακευτικοί φορείς.
ECSP961755A (es) Agentes antifungicos de peptidos ciclicos (caso x-9249)

Legal Events

Date Code Title Description
AHS Application shelved for other reasons than non-payment